Ray Fury
Executive Vice President, General Counsel, and Corporate Secretary
Replay available
Rigel Pharmaceuticals, Inc. (RIGL) Q4 2025 Earnings Call
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) Q4 2025 earnings conference call, held 2026-03-03. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Raul Rodriguez
President and Chief Executive Officer
Dave Santos
Chief Commercial Officer
Lisa Royker
Chief Medical Officer
Dean Shornow
Chief Financial Officer
Joe Pantinis
Analyst, HC Rainwright
Ashley Acker
Analyst, Piper Sandler
Farzeen Hakiu
Analyst, Jefferies
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Rigel Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:04.756 Greetings and welcome to the Rigel Pharmaceuticals Financial Conference Call for the 00:00:04.756 -- 00:00:07.859 fourth quarter and full year 2025. 00:00:07.859 -- 00:00:11.363 At this time, all participants are in a listen-only mode. 00:00:11.363 -- 00:00:15.508 A brief question and answer session will follow the formal presentation. 00:00:15.508 -- 00:00:20.153 If anyone should require operator assistance during the conference, please press star 00:00:20.153 -- 00:00:25.343 zero on your telephone keypad. As a reminder, this conference is being recorded. 00:00:25.343 -- 00:00:30.270 It is now my pleasure to introduce our first speaker, Ray Fury, Riesel's Executive Vice 00:00:30.270 -- 00:00:33.595 President, General Counsel, and Corporate Secretary. 00:00:33.595 -- 00:00:37.018 Thank you, Mr. Fury. You may begin. 00:00:37.782 -- 00:00:42.889 Welcome to our fourth quarter and full year 2025 financial results and business update 00:00:42.889 -- 00:00:46.975 conference call. The financial press release for the fourth quarter and the full year 00:00:46.975 -- 00:00:48.975 2025 00:00:50.421 -- 00:00:55.646 was issued a short while ago can be viewed along with the slides for this presentation 00:00:55.646 -- 00:01:00.873 in the news and events section of our investor relations site on risal.com. 00:01:00.873 -- 00:01:05.478 As a reminder, during today's call, we may make forward-looking statements regarding 00:01:05.478 -- 00:01:10.124 our financial outlook and our plans and timing for regulatory and product development. 00:01:10.124 -- 00:01:15.170 These statements are subject to risks and uncertainties that may cause actual results 00:01:15.170 -- 00:01:20.196 to differ from those forecasted. A description of these risks can be found...